Medtronic may sell spine business in wake of safety concerns over Infuse bone growth protein
Medtronic, maker of the Infuse bone-growth protein, may put its Spinal & Biologics business up for sale, according to media reports. Sales of the Infuse bone-growth protein fell sharply after reports of a government investigation into safety problems with the product. The company is now being hit with a growing number of personal injury lawsuits from patients who received the protein.
One study showed a possible higher rate of cancer among patients who got the growth protein during spine surgery. The types of cancer cited in the study include breast cancer, pancreatic cancer, and prostate cancer. If you or a loved one has been injured by Infuse, contact the attorneys at Jones Ward PLC for a free consultation. Call Jasper Ward at 502-882-6000 or email jasper@jonesward.com.
